NIDA
Consortium Focused on Identifying Chronic Pain Biomarkers Gets $1.9M Boost
The additional funds from the National Institute on Drug Abuse will allow the Acute to Chronic Pain Signatures Consortium to keep researching biomarkers that can predict which patients are at risk.